Frontiers in Cardiovascular Medicine

FEBRUARY 18, 2025

However, studies on diagnostic markers related to cellular senescence in acute myocardial infarction (AMI) have not been reported. IntroductionCellular senescence can cause heart failure.

Myocardial Infarction 52

Myocardial Infarction Heart Failure Research 52

Frontiers in Cardiovascular Medicine

FEBRUARY 6, 2025

Cardiovascular diseases are the most lethal diseases worldwide, of which myocardial infarction is the leading cause of death.

Myocardial Infarction 52

Myocardial Infarction Cardiovascular Disease Research 52

Frontiers in Cardiovascular Medicine

FEBRUARY 19, 2025

The main content of this paper is to explore the application of stem cells and gene technology in the treatment of myocardial infarction (MI). It has become an urgent task for clinical medicine to seek new and better treatment.

Myocardial Infarction 52

Myocardial Infarction Quality of Life Heart Transplant Ischemia 52

Cardiology Update

JUNE 16, 2024

However, the association between vessel-level coronary atherosclerotic plaque activity and the incidence of vessel-level myocardial infarction (MI) has not been fully explored. This included an elevated risk of cardiac death or myocardial infarction (HR: 2.43; 95% CI: 1.37-4.30; 4.39; P = 0.002) myocardial infarctions.

Myocardial Infarction 98

Myocardial Infarction Plaque Coronary Artery Disease Research 98

Frontiers in Cardiovascular Medicine

FEBRUARY 24, 2025

ObjectiveThis study aimed to evaluate the correlation between aerobic exercise intensity based on the 6min walk test (6MWT) and the anaerobic threshold (AT)-based equivalent in patients with acute myocardial infarction (AMI).

Myocardial Infarction 52

Myocardial Infarction Exercise Hospital Research 52

Frontiers in Cardiovascular Medicine

JANUARY 23, 2025

Background Early prediction of heart failure (HF) after acute myocardial infarction (AMI) is essential for personalized treatment.

Myocardial Infarction 52

Myocardial Infarction Heart Failure Research Hospital 52

Dr. Smith's ECG Blog

DECEMBER 11, 2023

Occlusion myocardial infarction is a clinical diagnosis Written by Willy Frick (@Willyhfrick). St depression in lead AVL differentiates inferior st-elevation myocardial infarction from pericarditis. link] Opiates are associated with worse outcomes in Myocardial Infarction. Circulation , 130 (25). Worrall, C.,

Myocardial Infarction 123

Myocardial Infarction Chest Pain STEMI Blood Pressure 123

JAMA Cardiology

AUGUST 6, 2024

This secondary analysis of the Valsartan in Acute Myocardial Infarction (VALIANT) and Prospective ARNi vs ACE Inhibitor Trial to Determine Superiority in Reducing Heart Failure Events After MI (PARADISE-MI) randomized clinical trials investigates the changes over time in sudden death rate after myocardial infarction and the characteristics of people (..)

Myocardial Infarction 95

Myocardial Infarction ACE Inhibitor Heart Failure 95

Open Heart

JANUARY 21, 2025

Background Atrial fibrillation (AF) and acute myocardial infarction (AMI) share risk factors and are bidirectionally associated. Several studies found higher risks of outcomes in individuals with both conditions. Whether the risks of outcomes differ according to temporal order of AF and AMI is unclear.

Myocardial Infarction 52

Myocardial Infarction Atrial Fibrillation Diet Cancer 52

Cardiovascular Diabetology

JANUARY 3, 2025

Yet, the impact of GLP-1RA treatment before ST-segment elevation myocardial infarction (STEMI) on. Glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment reduces cardiovascular events in type 2 diabetes.

Myocardial Infarction 115

Myocardial Infarction Diabetes STEMI Research 115

Frontiers in Cardiovascular Medicine

FEBRUARY 24, 2025

IntroductionAcute coronary syndrome refers to a group of diseases characterized by sudden, decreased blood supply to the heart muscle that results in cell death, also known as acute myocardial infarction. The majority of patients (67.9%) have been diagnosed with ST- Elevated Myocardial Infarction and were classified as Killip class I.

Hospital 98

Hospital Myocardial Infarction Chest Pain Electrocardiogram 98

Frontiers in Cardiovascular Medicine

DECEMBER 3, 2024

However, whether immediate blood glucose and FIB levels affect coronary blood flow during primary percutaneous coronary intervention (PCI) remains unclear.ObjectiveTo explore the correlation between admission blood glucose (ABG), fibrinogen (FIB) and slow blood flow during primary PCI for acute ST segment elevation myocardial infarction (STEMI).MethodsA

Myocardial Infarction 52

Myocardial Infarction STEMI Risk Factors Hospital 52

Open Heart

FEBRUARY 17, 2025

Background Despite limited beneficial evidence, mechanical circulatory support (MCS) is commonly used in patients with acute myocardial infarction-related cardiogenic shock (AMI-CS). In this Dutch registry, we investigated MCS usage, associated patient characteristics and clinical outcomes.

Cardiogenic Shock 52

Cardiogenic Shock Myocardial Infarction Aortic Outcomes 52

Heart BMJ

SEPTEMBER 25, 2024

In the beginning of the 20th century, the first reports of the clinical manifestations of myocardial infarction (MI) appeared, followed around a decade later by reports regarding the electrocardiographic (ECG) changes associated with MI ( figure 1 ).

Myocardial Infarction 98

Myocardial Infarction Document 98

DAIC

JULY 10, 2024

a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced success from a collaborative Phase II trial of ProtheraCytes for the treatment of acute myocardial infarction (AMI) led by CellProthera , as well as plans to continue the relationship into Phase III.

Myocardial Infarction 105

Myocardial Infarction Heart Failure Heart Attack Heart attacks 105

The New England Journal of Medicine

FEBRUARY 12, 2025

In a randomized trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse cardiovascular events over a median follow-up period of 3 years.

Myocardial Infarction 71

Myocardial Infarction 71

HeartRhythm

DECEMBER 31, 2024

Curtain etal1 performed an analysis of the VALIANT (Valsartan in Acute Myocardial Infarction) and PARADISE-MI (Prospective ARNi vs ACE Inhibitor Trial to Determine Superiority in Reducing Heart Failure Events After MI) trials to evaluate whether risk of sudden cardiac arrest (SCA) following acute myocardial infarction (MI) has changed over time.

Cardiac Arrest 79

Cardiac Arrest ACE Inhibitor Myocardial Infarction Heart Failure 79

Circulation

FEBRUARY 13, 2025

The development of coronary care units is often credited for a dramatic decline in mortality rates after acute myocardial infarction throughout the 1960s. As the underlying patient population became progressively sicker, changes in organizational structure, staffing, care delivery, and training paradigms lagged.

Critical Care 72

Critical Care Myocardial Infarction Research Cardiovascular Disease 72

Open Heart

JANUARY 17, 2024

Objective In the COVERT-MI randomised placebo-controlled trial, oral administration of high-dose colchicine at the time of reperfusion and for 5 days in acute ST-elevated myocardial infarction did not reduce infarct size but was associated with a significant increase in left ventricular thrombus (LVT) in comparison to placebo.

Myocardial Infarction 96

Myocardial Infarction Quality of Life Heart Failure Stroke 96

American College of Cardiology

OCTOBER 29, 2024

The goal of the CLEAR SYNERGY OASIS 9 trial was to determine the long-term cardiovascular (CV) effects of colchicine following percutaneous coronary intervention (PCI) for ST-segment elevation or large non–ST-segment elevation myocardial infarction (STEMI or NSTEMI, respectively).

Myocardial Infarction 66

Myocardial Infarction STEMI Article 66

Frontiers in Cardiovascular Medicine

DECEMBER 9, 2024

BackgroundMyocardial infarction(MI) is one of the most serious health threats.

Myocardial Infarction 52

Myocardial Infarction Research 52

JAMA Cardiology

JUNE 17, 2024

This genetic association study evaluated genetic variants associated with increased risk of vasospastic angina.

Angina 108

Angina Myocardial Infarction 108

HCPLive

APRIL 12, 2024

Ankeet Bhatt, MD, MBA, discusses a NUDGE-FLU analysis from ACC.24 24 examining effect of the CV gain-framed nudge in patients with and without history of AMI.

Myocardial Infarction 119

Myocardial Infarction 119

Frontiers in Cardiovascular Medicine

JANUARY 15, 2024

Background The diagnosis of a left ventricular (LV) thrombus in patients with ST-segment elevation myocardial infarction (STEMI) remains challenging. The aim of the current study is to characterize clinical predictors for LV thrombus formation, as detected by cardiac magnetic resonance imaging (CMRI). and 59%, respectively.

Myocardial Infarction 80

Myocardial Infarction STEMI Hospital 80

Cardiovascular Diabetology

MAY 26, 2024

Stress hyperglycemia, which is associated with poor prognosis in patients with acute myocardial infarction (AMI), can be determined using the stress hyperglycemia ratio (SHR). Impaired left ventricular functio.

Myocardial Infarction 78

Myocardial Infarction Research 78

Frontiers in Cardiovascular Medicine

MARCH 25, 2025

ObjectivesExercise training is a rehabilitative approach to improve cardiac function in patients with myocardial infarction. However, evidence on the effectiveness of exercise training in these patients remains limited.

Myocardial Infarction 52

Myocardial Infarction Exercise Cardiac Function Pharmacology 52

Cardiovascular Diabetology

JANUARY 17, 2025

The aim of this study was to investigate the difference between perceived and calculated diabetes risks among post-myocardial infarction (AMI) patients using the Finnish Diabetes Risk Score (FINDRISC).

Myocardial Infarction 64

Myocardial Infarction Diabetes Research 64

Frontiers in Cardiovascular Medicine

OCTOBER 7, 2024

BackgroundCardiac rupture (CR) after acute myocardial infarction (AMI) is a fatal mechanical complication. The early identification of factors related to CR in high-risk cases may reduce mortality. and in-hospital mortality was approximately 57%.

Myocardial Infarction 59

Myocardial Infarction Risk Factors Hospital 59

Med Page Today

JUNE 26, 2024

(MedPage Today) -- Influenza infection was associated with an increased risk of acute myocardial infarction (MI), especially for those without a prior hospitalization for coronary artery disease (CAD), according to a Dutch observational case series.

Heart Attack 143

Heart Attack Heart attacks Coronary Artery Disease Myocardial Infarction 143

JAMA Cardiology

SEPTEMBER 1, 2024

This post hoc analysis of a randomized clinical trial analyzes imaging data for atheroma volume at the lesion level from patients who received intensive lipid-lowering therapy with alirocumab plus statin compared with a statin alone.

Myocardial Infarction 102

Myocardial Infarction 102

Frontiers in Cardiovascular Medicine

NOVEMBER 17, 2024

Multiple logistic regression and restricted cubic spline (RCS) analyses were conducted to assess both linear and nonlinear associations between WWI and myocardial infarction. Subgroup analyses and interaction tests were also performed.ResultsAmong the 31,535 participants analyzed, 1,449 (4.82%) had experienced a myocardial infarction.

Myocardial Infarction 59

Myocardial Infarction BMI Angina Obesity 59

Cardiovascular Diabetology

JANUARY 21, 2025

The impact of sodiumglucose cotransporter-2 (SGLT2) inhibitors on mortality following myocardial infarction (MI) remains uncertain. Additionally, the role of type 2 diabetes mellitus (T2DM) and heart failure.

Myocardial Infarction 64

Myocardial Infarction Heart Failure Diabetes Research 64

Journal of the American Heart Association

FEBRUARY 26, 2025

BackgroundCardiorenal syndrome type 1 is characterized by the development of acute kidney injury following acute cardiac illness and notably acute myocardial infarction (MI). Journal of the American Heart Association, Ahead of Print.

Myocardial Infarction 75

Myocardial Infarction Risk Factors 75

Frontiers in Cardiovascular Medicine

FEBRUARY 13, 2025

Specific cardiovascular diseases, such as acute myocardial infarction, arrhythmias, pulmonary hypertension and pericarditis, were also pointed. SiO2 exposure was linked to an increased risk of myocardial infarction, with potential mechanisms involving inflammation and platelet activation.

Myocardial Infarction 52

Myocardial Infarction Biomarkers Pericarditis Cardiovascular Disease 52

European Journal of Heart Failure

DECEMBER 26, 2024

HF, heart failure; LVEF, left ventricular ejection fraction; MI, myocardial infarction. Abstract Aims In the EMPACT-MI trial, empagliflozin reduced heart failure (HF) hospitalizations but not mortality in acute myocardial infarction (MI). Glycaemic status and diabetes in EMPACT-MI.

Myocardial Infarction 69

Myocardial Infarction Diabetes Heart Failure Hospital 69

Journal of the American Heart Association

MARCH 7, 2025

The primary outcome was device success and allcause death, while secondary outcomes included myocardial infarction, stroke, and heart failure hospitalization rates at 30day and intermediateterm followup. Studies with <5 patients were excluded. A fixedeffects metaanalysis was used to estimate pooled rates.

Cardiogenic Shock 45

Cardiogenic Shock Bicuspid/Mitral Myocardial Infarction Heart Failure 45

Dr. Smith's ECG Blog

JANUARY 17, 2025

ECG Patterns of Occlusion Myocardial Infarction: A Narrative Review

Myocardial Infarction 52

Myocardial Infarction Article 52